MYR 0.4
(1.25%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 240.66 Million MYR | -8.98% |
2022 | 264.4 Million MYR | 18.65% |
2021 | 222.84 Million MYR | 43.56% |
2020 | 155.22 Million MYR | -3.81% |
2019 | 161.37 Million MYR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 68 Million MYR | 20.54% |
2024 Q1 | 56.41 Million MYR | -9.44% |
2023 Q2 | 66.95 Million MYR | 16.94% |
2023 Q4 | 62.29 Million MYR | 15.01% |
2023 Q1 | 57.25 Million MYR | -21.53% |
2023 FY | 240.66 Million MYR | -8.98% |
2023 Q3 | 54.16 Million MYR | -19.1% |
2022 Q3 | 71.98 Million MYR | 0.0% |
2022 FY | 264.4 Million MYR | 18.65% |
2022 Q4 | 72.96 Million MYR | 1.37% |
2021 FY | 222.84 Million MYR | 43.56% |
2020 FY | 155.22 Million MYR | -3.81% |
2019 FY | 161.37 Million MYR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Artroniq Berhad | 38.33 Million MYR | -527.87% |
Optimax Holdings Berhad | 114.11 Million MYR | -110.899% |
Pharmaniaga Berhad | 3.4 Billion MYR | 92.931% |
Apex Healthcare Berhad | 936.16 Million MYR | 74.292% |